Euro-BioImaging update regarding COVID-19


Published April 7, 2020
Scientific application

Following closely the Covid-19 situation, Euro-BioImaging asks everyone involved, including Euro-BioImaging users, to align with the recommendations of their relevant national health departments.

Euro-BioImaging will process the online submission of new user proposals as before, but flexibility needs to be applied when it comes to scheduling a physical user visit until available information on the European situation allows again for reliable and safe travel planning. Euro-BioImaging is also looking into the implementation of additional activities and services that do not require physical traveling and ways to keep a constructive momentum during these exceptional times.

Regarding any upcoming meetings, Euro-BioImaging will continue following the general development and act in accordance.


More news from Euro-BioImaging

Representative MRI images of livers.

September 16, 2025

Spotlight - Johnson Lok – Advanced Microbiome Therapeutics (AMT)

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is the most prevalent liver disease globally, yet no therapies…

Synchrotron 3D reconstructions

September 16, 2025

Exploring the role of 3D architecture in dental peri-Implant tissue healing

Peri implant connective tissue consistently forms an organised fiber arrangement around the implant neck during healing. Whithin this framework, X-ray phase-contrast (XPCT) imaging offers…

SEE-LIFE funding - deadline extended

September 16, 2025

SEE-LIFE Funding for imaging projects in Italy

We are delighted to announce that the MultiModal Molecular Imaging Italian Node and the Advanced Light Microscopy (ALM) Italian Node are providing free-of-charge access…